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ABSTRACT 
 
The immune system is a group of structures and processes that protect us from 
disease. In order to function properly it must recognize a wide variety of pathogens such 
as viruses and bacteria; but, must also distinguish these pathogens from the hosts own 
tissue. T cells play a crucial role in an immune response against these pathogens through 
many different mechanisms. However, an overactive immune response can lead to 
autoimmune diseases, therefore it is important that the immune system has the ability to 
negatively regulate an immune response and maintain homeostasis. In the periphery, 
regulatory T cells (CD4
+
CD25
+
Foxp3
+
) are involved in the maintenance of self-tolerance 
and immune homeostasis. 
Tregs express the transcription factor Foxp3 which is involved in the positive and 
negative regulation of multiple genes that are involved in Treg function. A mutation in 
the foxp3 gene results in the fatal autoimmune disease Immunodysregulation 
Polyendocrinopathy Enteropathy X-linked syndrome (IPEX) in humans and Scurfy in 
mice. Treg dysfunction has also been associated with other diseases such as cancer, 
allergy, inflammatory bowel disease (IBD), multiple sclerosis (MS), and infection. 
Therefore, elucidating the mechanisms by which Tregs are induced may lead to 
advancements in the establishment of Treg based therapeutics for the aforementioned 
human diseases. 
 
 x 
There are two main subsets of Tregs: naturally arising Tregs (nTregs) and 
inducible Tregs (iTregs). Natural Tregs develop in the thymus while iTregs differentiate 
from naïve CD4
+
 T cells in the periphery. We have previously demonstrated that human 
umbilical cord blood (UCB) has an increased capacity for iTreg differentiation than 
human adult peripheral blood mononuclear cells (PBMCs). While effector CD4
+
 T cells 
transiently up-regulate Foxp3 expression upon T cell receptor (TCR) stimulation, human 
Tregs stably express the transcription factor. Stable expression of Foxp3 is a marker for 
both nTregs and iTregs with functional suppressive capability. 
Many mechanisms are involved in the induction of iTregs from naïve CD4
+
 
T cells which can include cytokine signaling as well as epigenetic modifications that 
control gene expression. These mechanisms may be utilized for the differentiation of 
iTregs by regulating the expression of genes require for the function of iTregs such as 
Foxp3; therefore, I investigated which epigenetic histone modifications and cytokines 
that may be involved in iTreg differentiation in an ex vivo human UCB model. 
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CHAPTER ONE 
LITERATURE REVIEW 
 
Introduction 
 The immune system is a collection of tissues and processes that protect us from 
pathogens such as bacteria, viruses and parasites; but must also distinguish pathogens 
from self-tissue. An adaptive immune response, or pathogen specific response, is 
orchestrated through the action of many immune cells including CD4
+
 T lymphocytes. 
CD4
+
 T cells can mediate an immune response through a variety of mechanisms which 
involves communication with other immune cells through cytokine and chemokine 
production. CD4
+ 
T cells can also assist B cells in antibody production and macrophages 
by enhancing their activity to fight infections, thus the name T helper cell (Th). T cells 
express T cell receptors (TCR) on their cell surface capable of recognizing peptides 
derived from pathogens presented on major histocompatibility complex 
class II (MHC class II) that are expressed by antigen presenting cells (APCs). This 
interaction mediates downstream signaling through TCR that promote the transcription of 
many genes including cytokines and proteins that promote differentiation and function. 
 It has been established that T helper cell differentiation is very complex since 
many subsets have been reported inducing: Th1, Th2, Th9, Th17, and Tregs (1,2). Each 
of these subsets are characterized though specific function and cytokine production such
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 as interferon gamma (IFN γ) production for Th1 responses. All subsets must operate in 
concert in order for appropriate immune response to be mounted, the infection cleared, 
and discontinuation of the response along with establishment of memory. Autoimmunity 
occurs when an immune response is uncontrolled and has mounted a response against 
self-tissue; hence, the requirement to negatively regulate an inappropriate immune 
response is essential. 
 
Regulatory T cells 
Regulatory T cells mediate immune responses to maintain self-tolerance and 
immune homeostasis. Gershon and Kondo discovered a T cell subset that was able to 
diminish an immune response and were dissimilar from helper T cells (3). These cells, 
entitled suppressor T cells were continuously studied with results that fluctuated 
considerably. It was thought that the I-J molecule associated with MHC was supposed to 
elicit this suppressive function; however, this turned out to be untrue (4). Interest 
declined because no phenotypic markers could be determined until Sakaguchi discovered 
that CD4
+
CD25
+
 cells could down-regulate an immune response (5). CD25 is the 
interleukin 2 receptor α chain and is expressed on 5-10% of CD4+ T cells in the periphery 
(5). It has been established that CD25 expression and IL-2 signaling is essential for the 
proliferation and differentiation of Treg cells (6). Sakaguchi was able to transfer 
CD4
+
CD25
-
 or CD4
+
CD25
+
 T cells into lymphocyte deficient mice and mice receiving 
the CD4
+
CD25
-
 T cells developed apparent autoimmune disease while mice that received 
CD4
+
CD25
+
 cells did not (5). These data verify that Tregs have suppressive function 
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essential for self-tolerance and immune homeostasis and this function is dependent on 
interleukin 2 (IL-2). 
It was not known what regulated this suppressive function until Bennett et al. 
found that mutations in the foxp3 gene resulted in Scurfy mice, exhibiting autoimmune 
diseases including splenomegaly and lymphadenopathy, and the fatal autoimmune 
disease Immunodysregulation Polyendocrinopathy Enteropathy X-linked 
syndrome (IPEX) in humans (7). Further studies reported that Foxp3  (forkhead box P3) 
was specifically expressed in CD4
+
CD25
+
 cells and overexpression of Foxp3 in 
CD4
+
CD25
-
 non-Treg cells could generate cells with a Treg-like phenotype (9). These 
findings suggested that Foxp3 was the master regulator and CD4
+
CD25
+
Foxp3
+
 became 
the characteristic phenotype for Tregs. It has also been shown that CD8
+
Foxp3
+
 cells also 
have immunosuppressive capabilities (8). However, CD8
+
 Treg cells represent a novel 
Treg subset with findings still in its infancy. Foxp3 is a transcription factor that is a 
member of the forkhead/winged-helix family of transcriptional regulators and has a fork 
head (FKH) domain that binds to DNA thereby positively and negatively regulating gene 
expression important for Treg function (10). 
Multiple mechanisms have been proposed for the suppressive function of 
CD4
+
CD25
+
Foxp3
+
 Treg cells. Hori et al. showed that Treg cells required antigenic 
simulation through TCR signaling in order to suppress cells associated with an immune 
response (9). Cytokine production as well as APC interaction has also been proposed as a 
mechanism by which Tregs can down-regulate an immune response. Nakamura et al. has 
demonstrated that transforming growth factor beta (TGF-β) bound to the cell surface of 
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Tregs was also essential for Treg function (11). Oderup et al. showed that Treg 
interaction with dendritic cells (DCs) could down regulate the co-stimulatory 
molecule B7 on the DC cell surface; thus, inhibiting the activation of responder cells (12). 
These results suggest that Treg cells suppress an immune response through direct or 
indirect mechanisms. 
 There are two subsets of Tregs: natural Tregs (nTregs) that develop in the thymus 
and inducible Tregs (iTregs) that develop in the periphery (13). Naïve CD4
+ 
T cells in the 
periphery can be stimulated to differentiate into iTregs through antigen presentation in 
the presence of TGF-β and these iTregs also express Foxp3; however, Foxp3 is not as 
stable in iTregs as it is in nTregs (13,14). It has been proposed that due to the variation in 
the way these two subsets develop, there may be dissimilar mechanisms of Foxp3 
regulation (13). Many factors play a role in the generation of iTregs in the periphery 
which include exposure to antigen, cytokines, and APCs (13). All of these factors 
transmit signals throughout the cell which collectively determine and regulate the 
transcription of genes. 
 
Epigenetics 
 Gene transcription can be regulated through an assortment of mechanisms 
including epigenetic modifications. Such modifications can include DNA methylation 
and histone modifications that can change the structure of DNA but not its sequence (15). 
This change in structure has downstream effects on the transcription of genes which may 
play a role in the differentiation of iTregs (14,15). DNA can be methylated at the 
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5’ position of cytosine nucleotide when it occurs next to a guanine nucleotide (CpG) and 
DNA methyltransferases are involved in the maintenance of methylation during cell 
differentiation (15). Core histone molecules are organized into octamers consisting of two 
of each histone protein H2a, H2b, H3 and H4 and this octamer forms a complex with 
DNA known as a nucleosome (15). Modifications including acetylation, phosphorylation, 
methylation and ubiquitination, take place at highly conserved amino acid residues at the 
tail region of histone proteins and these modifications work together to influence the 
folded state of the chromatin (15). Open chromatin, or euchromatin, allows gene 
expression by permitting the binding of transcriptional machinery to the DNA at the 
promoter of a gene (15). 
 Floess et al. has demonstrated that both DNA methylation and histone 
modifications are mechanisms by which Foxp3 is regulated in Tregs (14). CpG motifs 
within amplicons 1 and 2 showed a high degree of methylation on CD4
+
CD25
-
 
conventional T cells; whereas, in CD4
+
CD25
+
 Tregs this region was almost completely 
de-methylated which permits transcription (14). No changes in the methylation status 
between amplicon 3 and 4 suggests that this change in methylation is not random (14). 
Floess et al. also demonstrates that pro-transcriptional modifications tri-methylation of 
histone protein H3 at lysine residue 4 (H3K4me3) and acetylation of histone 
protein H3 (H3ac) at the Foxp3 locus has a stronger association with CD4
+
CD25
+
 Tregs 
when compared to CD4
+
CD25
-
 conventional T cells (14). These data suggests that DNA 
methylation and histone modifications are vital for the expression of Foxp3 and function 
of Tregs. 
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Cytokines signaling 
 Cytokine milieus are an important factor in cell signaling and are a key regulator 
in the differentiation of all immune cells. These small proteins bind to their cognate 
receptors and mediate an intracellular signaling cascade that results in alteration of gene 
expression. Classification of receptors is based upon the extracellular structure. This 
includes the IL-2 receptor family, growth hormone (GH) family, interferon (IFN) family, 
glycoprotein 140 (gp140) family and TGF-β receptor family, among many others (16). 
Cytokine receptors are vital as they are responsible for receiving a signal through 
cytokine binding and are also responsible for transmitting that signal to downstream 
target proteins. 
 TGF-β is a pleiotropic cytokine that binds to the TGF-β receptor and facilitates 
proliferation, differentiation and apoptosis of many cells and can be produced by many 
cells types including lymphocytes and macrophages (17). TGF-β has 3 isoforms; 
TGF-β 1, 2, and 3, and has been implicated in many diseases such as cancer, heart disease, 
diabetes, and AIDS (18). It has been established that TGF-β is a critical factor in T cell 
immune homeostasis as a T cell specific deletion of the TGF-β receptor II in mice results 
in lethal inflammation (20,19). Intracellular transducers that are activated upon TGF-β 
stimulation include Smads and Ross et al has shown that Smad2 mediated gene 
transcription requires the histone acetyltransferase p300 for acetylation of H3K9 at 
promoter regions to promote gene expression (21). These data support the idea that 
TGF-β signaling is required for regulating T cell immune homeostasis and regulation of 
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gene transcription; furthermore, Smads depend on histone remodeling to promote gene 
expression. 
 It is known that regulatory T cells are required for peripheral tolerance and Li et 
al. has shown that the number of Tregs declines when TGF-β receptor II is deleted in 
T cells; however, the number of Tregs in the thymus was unchanged (19). This 
demonstrates the importance of TGF-β to the peripheral maintenance of iTregs. 
Furthermore, Chen et al demonstrated that naïve CD4
+
 T cells were able to differentiate 
into Foxp3
+
 iTregs in the periphery with TCR stimulation in the presents of TGF-β (22). 
The expression of Foxp3 is mediated by TGF-β activation of Smad3 which translocates 
to the nucleus and associates with the foxp3 promoter (23). These data indicate that 
TGF-β is required for the differentiation of iTregs in the periphery through the regulation 
of chromatin structure and gene expression important for iTreg function. 
 Interleukin-3 (IL-3), also known as multi-lineage colony stimulating 
factor (Multi-CSF), is a cytokine that is secreted by activated T cells and can stimulate 
the proliferation and differentiation of pluripotent hematopoietic stem cells (24,25). IL-3 
is also capable of promoting growth and differentiation of neutrophils, macrophages, 
lymphoid and erythroid cells by binding to the IL-3 receptor which is a member of the 
gp140 family (26). Treg dysfunction has been implicated in many autoimmune diseases 
and mounting evidence has linked autoimmunity to cancer; additionally, dysfunction in 
IL-3 signaling may play a role in immune imbalances that are associated with these 
diseases (27). One example is classical Hodgkin’s disease which is a form of lymphoma 
characterized by low tumor frequency Hodgkin’s and Reed/Sternberg cells (H-RS) (28). 
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Aldinucci et al. has shown that these H-RS cells express the IL-3 receptor and exogenous 
IL-3 can promote the growth and inhibit apoptosis of these cells (28). IL-3 is important 
for the differentiation of hematopoietic stem cells, thus it is important for the generation 
of all cell types found in the blood; however, under inappropriate circumstances can 
allow proliferation and anti-apoptotic signals to tumor cells. 
 An increasing amount of evidence suggests that IL-3 may play a role in the 
differentiation of naïve CD4
+
 T cells to iTregs in the periphery. Seivastava et al. has 
demonstrated that the IL-3 receptor is expressed by iTregs and IL-3 enhances the 
frequency of Foxp3
+
 T cells through the indirect secretion of IL-2 by non-Treg cells (25). 
Signal transducers and activators of transcriptions (STATs) are activated when IL-3 binds 
to its cognate receptor (25,26,29). Nakajima et al shows that STAT5
-/-
 splenocytes have a 
decrease in IL-2 receptor α chain/CD25 mRNA compared to wild type cells (30). 
Furthermore, Antov et al determined that Treg number and function is defective in 
STAT5 knockout mice (29). These data propose that IL-3 may be important for iTreg 
differentiation and proliferation through the activity of STAT5. 
 
Proposed model 
 We have previously discovered that an ex vivo human umbilical cord 
blood (UCB) culture system has an increased capacity for the differentiation of iTregs 
than adult peripheral blood mononuclear cells (PBMCs). However, it is not completely 
understood what mechanisms and signals are required for the differentiation of iTregs 
from UCB. Cytokine signaling and epigenetic modifications of histone tail residues are 
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well known mechanisms that regulate gene expression. Hence, we propose a model that 
iTreg differentiation from human UCB utilizes histone modifications mediated through 
TGF-β signaling as well as IL-3 signaling, a novel cytokine for iTreg proliferation, 
differentiation and cell survival. 
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CHAPTER TWO 
MATERIALS AND METHODS 
 
Isolation of mononuclear cells from umbilical cord blood 
Human umbilical cord blood (UCB) was collected at Gottleib Memorial Hospital 
without any identifying information. UCB samples were collected into sterile, 
anticoagulant treated BLOOD-PACK
™
 units (Fenwal, Inc., IL) and were diluted 1:1 with 
1x PBS at room temperature. Mononuclear cells were then enriched by ficoll-hypaque 
density gradient centrifugation using lymphocyte separate media (Cellgro). The buffy 
coat layer containing mononuclear cells was then extracted by pipetting. The procedure 
was repeated to reduce red blood cell contamination. Mononuclear cells are collected, 
counted, and subjected to flow cytometry or cell culture. Total CD4+ T cells were 
enriched from whole UCB (WCB) mononuclear cells via BD IMag Enrichment Sets 
(Becton Dickinson) according to the protocol provided by the manufacturer. 
 
Culture Media 
 RPMI 1640 media (Thermo Scientific), supplemented with 10% FCS (Atlanta 
Biologicals), β-mercaptoethanol (50 µM), glutamine (2 mM), penicillin (100 I.U./mL), 
streptomycin (100 µg/mL), HEPES (10 mM), sodium pyruvate (1 mM), and MEM 
essential and non-essential amino acids (Invitrogen) were used in the experiments. 
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Cell Culture 
 Cells were cultured in 48 well plates in culture media. Cultures were 
supplemented with human IL-2 (PeproTech) at 10 ng/mL and α-CD3 (eBiosciences) at 
0.2 µg/mL. Cells were split every 2-3 days and IL-2 concentrations were maintained 
throughout culture. An inhibitor of TGF-β signaling, SB-431542 (Sigma-Aldrich) was 
added at 10 µM, anti-TGF-β (1,2,3) mouse mAb (R&D systems) was added at 2.5 ng/mL 
and recombinant human TGF-β (R&D systems) was added at a concentration of 
2.5 ng/mL where indicated. Human recombinant IL-3 (PeproTech) was added to culture 
at a concentration of 10 ng/mL and purified human anti-IL-3 (Biolegend) was added to 
culture at 1 µg/mL. TGF-β inhibitor SB-431542, anti-TGF-β(1,2,3), recombinant TGF-β, 
recombinant IL-3 and anti-IL-3 concentrations were all maintained throughout culture. 
 Polystyrene beads were incubated with 10 µg α-CD3 and 10 µg α-CD28 per 
100 µl bead suspension overnight at room temperature. Beads where then washed with 
1x PBS and blocked in 1x PBS with 10% BSA for 2 hours. After blocking, beads were 
re-suspended in cell culture media to 2x10
6
 beads per 50 µl media. For stimulation, 1x10
6
 
CD4
+
 cells were incubated with 50 µl beads for 1 hour at 37ºC before transferring to cell 
culture plate. 
 
Flow Cytometry 
 Fluorochrome-conjugated antibodies specific for CD3 (clone UCHT1), 
CD4 (clone RPA-T4), CD14 (clone HCD14), CD25 (clone BC96), CD36 (clone 5-271), 
and CD123 (clone 6H6) (Biolegend) CD8 (clone RPA-T8) and Foxp3 (clone 259D/C6) 
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(BD Biosciences) were used in the experiments. Cells were washed in FACS buffer (1% 
FCS, 0.1% sodium azide in 1x PBS) and then incubated with purified human IgG (R&D 
systems) for FC receptor blocking. Cells were then washed with FACS buffer and stained 
with the indicated antibodies at 4ºC for 30 minutes. For Foxp3 staining, cells were fixed 
and permeabilized using FOXP3 staining buffer set (Biolegend). Cells were washed twice 
with 1x PBS after cell surface staining followed by fixation with 500 µl fix/perm buffer 
for 20 minutes at room temperature. Tubes were then filled with FACS buffer and kept 
overnight at 4ºC. The next day cells were washed with FACS buffer and incubated in 
1x permeabilization buffer for 15 minutes at room temperature. Cells were then stained 
with anti-Foxp3 antibody for 30 minutes at room temperature followed by washing with 
FACS buffer. Data was collected on a flow cytometer (FACS Canto II, BD Biosciences) 
and analyzed using FlowJo software (TreeStar, Inc.). 
 
Histone Staining 
Cells are harvested and washed with FACS Buffer and incubated with purified 
human IgG for FC receptor blocking. After surface staining, cells are washed twice with 
FACS buffer followed by fixation and permeabilization with cytofix/cytoperm solution 
(BD Biosciences). Cells are then washed twice with perm/wash buffer (BD Biosciences). 
Phosphor-histone H3 (Ser10) (Alexa Fluor 488 conjugate), acetyl-histone H3 (Lys9) 
(C5B11) rabbit mAb (Alexa Fluor 488 conjugate), tri-methyl-histone H3 (Lys4) (C42D8) 
rabbit mAb (Cell Signaling), and anti-acetyl histone H4 (Lys8) (Millipore) are added and 
incubated at 4ºC for 1 hour. Cells are washed twice with perm/wash buffer. Goat 
13 
 
 
anti-rabbit IgG (H+L) fluorescein conjugated antibody (Millipore) was added as a 
secondary for H3K4 and H4K8 antibodies and incubated at 4ºC for 30 minutes. Cells are 
washed with perm/wash buffer and re-suspended in 200 µl FACS buffer. Data was 
collected on a flow cytometer (FACS Canto II, BD Biosciences) and analyzed using 
FlowJo software (TreeStar, Inc).
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CHAPTER THREE 
EXPERIMENTAL RESULTS 
 
Global Histone Modifications in CD4
+
 Treg cells and CD4+ non-Treg cells 
 Since iTregs (CD4
+
CD25
+
Foxp3
+
) express different genes than non-Treg T 
cells (CD4
+
CD25
-
Foxp3
-
), it is expected that Tregs use epigenetic modifications to 
control gene expression. During transcription, histone modifications are used to control 
the folded state of chromatin, therefore blocking or promoting gene transcription, and this 
alteration is controlled through an assortment of histone-modifying enzymes. Although, a 
variety of modifications are needed for full activation and repression of certain genes, a 
few important modifications that promote gene expression include H3K4 
tri-methylation (me3), H3K9 acetylation (ac), H3S10 phosphorylation (ph) and H4K8 
acetylation (ac). Floess et al. has shown that nTregs utilize H3 acetylation and H3K4me3 
to regulate expression of Foxp3 (14). Therefore, I hypothesized that the aforementioned 
histone modifications are globally altered in iTregs (CD4
+
CD25
+
Foxp3
+
) compared to 
non-Treg cells (CD4
+
CD25
-
Foxp3
-
) from UCB. Enriched CD4
+
 T cells stimulated with 
α-CD3 and α-CD28 coated beads with the addition of exogenous IL-2 do not induce 
iTreg differentiation and therefore will be the non-Treg (CD4
+
CD25
-
Foxp3
-
) control.  
First, we determined the Treg frequency of whole UCB (WCB) culture as well as CD4
+
 T 
cells simulated with beads by fluorescence activated cell sorting (FACS) after fourteen 
15 
 
 
days of culture (Figure 1). Tregs are characterized by the expression of the IL-2 
receptor α chain (CD25) and the transcription factor Foxp3. CD4+ cells from WCB 
expressed the highest levels of CD25 and Foxp3 while CD4
+
 cells after bead stimulation 
expressed very little Foxp3 with moderate CD25 expression as activated T cells do 
express CD25. 
 
 
Figure 1: FACS analysis of Treg frequency in ex vivo UCB. WCB cultures are 
stimulated with α-CD3 and IL-2 with or without the addition TGF-β inhibitor SB-431542 
or anti-TGF-β neutralizing antibody. DMSO treated WCB is used as a control. CD4+ 
cultures are stimulated with α-CD3 and α-CD28 coated polystyrene beads with the 
addition of IL-2 with or without exogenous TGF-β. Cells were harvested at day 14 and 
stained for CD4, CD25 and Foxp3. Cells are gated on CD4
+
 (Top panel) and Treg 
frequency is determined by CD25 and Foxp3 expression (Bottom panel). 
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To determine if histone modifications are altered in iTreg cells compared to 
non-Treg cells, WCB cells were cultured for fourteen days to induce iTreg differentiation 
with α-CD3 and IL-2. For non-Treg cultures, CD4+ cells where stimulated with beads as 
previously described. Cells where harvested and the histone modifications H3K4me3, 
H3K9ac, H3S10ph and H4K8ac was determined by FACS (Figure 2). These 
modifications are involved in remodeling the chromatin structure into euchromatin, or 
lightly packed chromatin, near promoter regions to allow binding of transcriptional 
machinery, thus promoting transcription. A decrease was observed for H3K4me3 and 
H3K9ac in CD4
+
 iTregs from WCB compared to CD4
+
 non-Tregs from bead stimulated 
cultures; however, no difference was seen in the level of H3S10ph and H4K8ac. The 
mean fluorescence intensity (MFI) also recapitulates this finding (Figure 2). At day five 
of culture, the decrease in H3K4me3 and H3K9 is apparent (Figure 3). This suggests that 
H3K4me3 and H3K9ac are being globally reduced to stop any unnecessary gene 
transcription while only genes involved in iTreg differentiation and function may be 
transcribed. H3S10ph and H4K8ac modifications are present within iTregs; however, 
their role may be important for transcription of housekeeping genes that are important for 
the survival of all cell types. 
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Figure 2: FACS analysis of histone modifications in Treg cells vs. Non-Treg cells at 
Day 14. WCB is stimulated with α-CD3 and IL-2. CD4+ cells are stimulated with α-CD3 
and α-CD28 coated polystyrene beads with the addition of IL-2. Cells are harvested at 
day 14 and stained with CD4, H3K4me4, H3K9ac, H4K8ac and H3S10ph. Cells are 
gated on CD4
+
 and then histone modifications are analyzed by histogram. MFI is 
reported above. 
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Figure 3: FACS analysis of histone modifications in Treg cells vs. Non-Treg cells at 
Day 5. WCB is stimulated with α-CD3 and IL-2. CD4+ cells are stimulated with α-CD3 
and α-CD28 coated polystyrene beads with the addition of IL-2. Cells are harvested at 
day 5 and stained with CD4, H3K4me4, H3K9ac, H4K8ac and H3S10ph. Cells are gated 
on CD4
+
 and then histone modifications are analyzed by histogram. MFI is reported 
above. 
 
TGF-β signaling is important for global alterations in histone modifications 
We have demonstrated that H3K4me3 and H3K9ac have decreased in Treg cells 
compared to non-Treg cells. One cytokine that has been shown to induce iTregs from 
naïve CD4
+ 
T cells is TGF-β (22). Many cells, such as monocytes, can secret TGF-β and 
it has been postulated that membrane bound TGF-β is present and important in our 
culture system. Activated TGF-β binds to the TGF-β receptor II and forms a heterodimer 
with the TGF-β receptor I which is required for kinase activity (31). Upon dimerization, 
the serine/threonine kinase domain phosphorylates a serine residue on TGF-β receptor I 
which mediates downstream signaling through the transducer proteins Smad2 and Smad3. 
Activated Smad2/3 have a high affinity for binding a co-Smad, Smad4, and this 
heterodimer complex translocates to the nucleus and can bind DNA and regulate gene 
expression (31). Ross et al. has shown that Smad2 requires the histone acetyltransferase, 
p300, to acetylate H3K9 in order to alter chromatin assembly at target genes (21). 
Next, we assessed if TGF-β signaling was important for modulating the decrease 
in global H3K4me3 and H3K9ac seen in iTreg cells from WCB. Since TGF-β is absent in 
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our CD4
+
 bead simulated non-Treg culture, exogenous TGF-β was added to culture. We 
hypothesized that iTreg frequency would be rescued and that H3K4me3 and H3K9ac 
would be similar to CD4
+
 iTreg cells from WCB. An increase in Treg frequency was seen 
in CD4
+
 bead stimulated cells when exogenous TGF-β was added when compared to 
CD4
+
 bead stimulated cells without TGF-β (Figure 1). Furthermore, H3K4me3 and 
H3K9ac are decreased in CD4
+
 bead stimulated cells with the addition of TGF-β similar 
to CD4
+
 iTreg cells from WCB. This observation was also reiterated by the decrease in 
the MFI seen in CD4
+
 bead simulated cells with the addition of exogenous TGF-β 
compared to CD4
+
 bead stimulated cells without TGF-β (Figure 4). 
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Figure 4: Effects of exogenous TGF-β addition to CD4+ bead stimulated culture on 
histone modifications. WCB is stimulated with α-CD3 and IL-2. CD4+ cells are 
stimulated with α-CD3 and α-CD28 coated polystyrene beads plus IL-2 with or without 
the addition of exogenous TGF-β. Cells are harvested at day 14 and stained with CD4, 
H3K4me4 and H3K9ac. Cells are gated on CD4
+
 and then histone modifications are 
analyzed by histogram. MFI is also reported. 
 
We subsequently sought to determine if the inhibition of TGF-β signaling in our 
WCB culture system would affect H3K4me3 and H3K9ac. We hypothesized that if 
TGF-β is required for the modulation of H3K4me3 and H3K9ac, than inhibiting TGF-β 
in our WCB culture system would increase the H3K4me3 and H3K9ac compared to 
untreated WCB and reduce Treg frequency. Both the TGF-β SB-431542 small molecule 
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inhibitor and an anti-TGF-β (1,2,3) neutralizing antibody were used in the experiments. 
The TGF-β inhibitor SB-431542 blocks the activity of the TGF-β superfamily type I 
activin receptor-like kinase (ALK4, ALK5 and ALK7) which forms a complex with 
TGF-β receptor II and mediates the downstream signaling of TGF-β (32). The 
anti-TGF-β (1,2,3) antibody neutralizes any TGF-β (1,2,3) present in culture by blocking 
the ability to induce its biological effects. CD4
+ 
cells from WCB cultures treated with 
TGF-β inhibitor or neutralizing antibody had a decrease in CD25 and Foxp3 expression 
compared untreated WCB; although, anti-TGF-β antibody did not have as great of an 
effect (Figure 1). Alternatively, no difference was detected in H3K4me3 and H3K9ac in 
CD4
+
 cells from WCB treated with TGF-β inhibitor SB-431542 or anti-TGF-β antibody 
compared to untreated WCB (Figure 5). When WCB was treated with TGF-β inhibitor 
SB-431542 and anti-TGF-β antibody, an increase in the frequency of CD4low cells was 
observed (Figure 5A). We then determined if H3K4me3 and H3K9ac was increased in 
the CD4
low
 and CD4
-
 populations. A slight increase in H3K4me3 and H3K9ac was seen 
in the CD4
low
 and the CD4
-
 populations when compared to untreated WCB. This increase 
is represented in the MFI when comparing untreated WCB to WCB treated with either 
the SB-431542 inhibitor or the anti-TGF-β antibody (Figure 5B). These data suggest that 
TGF-β may be playing a role in the orchestration of chromatin remodeling in order to 
regulate gene expression for the differentiation of iTregs from UCB. 
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Figure 5: Effects of TGF-β inhibition of WCB on histone modifications. WCB is 
stimulated with α-CD3 and IL-2 with or without the addition of either TGF-β inhibitor 
SB-431542 or anti-TGF-β antibody. Cells are harvested at day 14 and stained with CD4, 
H3K4me4 and H3K9ac. Cells are gated on CD4
+
 CD4
low
 or CD4
-
 (A) and then histone 
modifications are analyzed by histogram (B). MFI is also reported. 
 
CD4
low
 cells, surface markers, and Treg frequency of whole UCB  
 We next wanted to determine what these CD4
low
 cells were and if they were iTreg 
cells expressing CD25 and Foxp3. Monocytes express CD4 at low levels and can 
differentiation into plasmacytoid dendritic cells (pDC) (33). Stimulation of pDCs has 
been shown to induce CD4
+
CD25
+
 iTregs that are capable of inhibiting proliferation of 
autologous or allogeneic naïve CD4
+
 T cells in an antigen non-specific manner (34). An 
identifying surface marker for pDCs is CD123, the IL-3 alpha chain receptor (34). 
Therefore, we hypothesized that these CD4
low
 cells are either iTreg cells or monocytes 
that were differentiating into plasmacytoid dendritic cells (pDCs). 
To address this question, we stained un-stimulated cells at day zero for both T cell 
and monocyte surface markers to analyze the cells that are present in the starting material. 
TGF-β inhibitor SB-431542 was used in these experiments due to the increased 
frequency in CD4
low
 cells observed previously. After fourteen days of culture with α-CD3 
and IL-2 simulation, with or without TGF-β inhibitor SB-431542, the cells were stained 
again for the same surface markers. Treg frequency was also determined by FACS at day 
fourteen. At day zero, CD3
+
 T cells express either CD4 or CD8 and monocytes in UCB 
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express the surface markers CD14 and CD36 (Figure 6A).It has been previously shown in 
the lab that these monocytes have an increased propensity for the generation of iTregs. 
These monocytes also express CD4 at low levels (Figure 4B). Interestingly, 
CD14
+
CD36
hi
 monocytes are CD123
+
 while our CD3
+
 T cells are CD123
-
 (Figure 6B). 
 
 
 
Figure 6: Cell surface expression at Day 0. WCB is un-stimulated and stained with 
CD3, CD4, CD8, CD14, CD36 and CD123. Monocytes are gated on CD14
+
CD36
hi
 cells 
and T lymphocytes are gated on CD3
+
 cells. Expression of CD4 and CD8 is then views 
from CD3
+
 cells (A). Expression of CD4 and CD123 is viewed for CD3
+
 T lymphocytes 
and CD14
+
 CD36
hi
 monocytes (B). 
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After fourteen days of culture, cells were harvested and both surface staining and 
Treg staining was completed. All cells after fourteen days of culture are CD3
+
 T cells; 
thus, the CD4
low
 cells are not pDCs. The increase in the frequency of CD4
low
 cells was 
observed with TGF-β inhibition; however, these cells are also CD8+. Sullivan et al has 
shown that up-regulation of CD4 on CD8
+
 cells results in the increased expression of 
activation markers such as CD95, CD28, and CD25 when compared to CD8
+
CD4
- 
cells 
suggesting that CD4 expression on CD8
+ 
cells is an additional marker to identify 
activated CD8
+
 T cells (35). It has also been shown that populations of CD8
+
Foxp3
+
 
Tregs are vital for protection against graft-versus-host disease (GVHD) (8). However, 
CD8
+
 Tregs have not been well characterized in our UCB model. We analyzed the Treg 
frequency of each of the populations in the CD4 and CD8 profile. Cells that are CD4
+
 
and express CD8 at low levels had an increase in Treg frequency when compared to 
CD4
+
CD8
-
 cells. The same was also seen in cells that are CD8
+
 and express CD4 at low 
levels when compared to cells that are CD8
+
CD4
-
 (Figure 7). Foxp3 and CD25 
expression is also increased in CD8
+
CD4
low 
and CD4
+
CD8
low
 compared to CD8
+
CD4
-
 
and CD4
+
CD8
-
 respectively (Figure 8). This suggests that these CD8
+
CD4
low 
and 
CD4
+
CD8
low
 cells are a more activated population of iTregs. Cultures with TGF-β small 
molecule inhibitor treatment show a flattened shape when looking at CD25 and Foxp3 
expression in all populations signifying a decrease iTreg differentiation (Figure 7). 
Surprisingly, we also observed that the CD4
+
CD8
-
 and CD4
+
CD8
low
 cells expressed 
CD123 at day fourteen while CD8
+
CD4
-
 and CD8
+
CD4
low
 cells do not (Figure 9).  
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Figure 7: Treg frequency of CD4/CD8 populations in WCB. WCB cultures are 
stimulated with α-CD3 and IL-2 with or without the addition of TGF-β inhibitor 
SB-435142. DMSO treatment is used as a control. Cells were harvested at day 14 and 
stained for CD4, CD8, CD25 and Foxp3. Cells are gated on CD4
+
CD8
-
, CD4
+
CD8
low
, 
CD8
+
CD4
-
 and CD8
+
CD4
low
 (A). Treg frequency is determined by CD25 and Foxp3 
expression (B). 
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Figure 8: Foxp3 and CD25 expression in CD4
+
CD8
-
 vs. CD4
+
CD8
low
 and CD8
+
CD4
-
 
vs. CD8
+
CD4
low
. WCB cultures are stimulated with α-CD3 and IL-2. Cells were 
harvested at day 14 and stained for CD4, CD8, CD25 and Foxp3. Foxp3 expression is 
observed in CD4
+
CD8
-
 vs. CD4
+
CD8
low
 and CD8
+
CD4
-
 vs. CD8
+
CD4
low
 (A). CD25 
expression is observed in CD4
+
CD8
-
 vs. CD4
+
CD8
low
 and CD8
+
CD4
-
 vs. 
CD8
+
CD4
low
 (B). 
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Figure 9: CD123 expression on CD4/CD8 populations. WCB cultures are stimulated 
with α-CD3 and IL-2. Cells were harvested at day 14 and stained for CD3, CD4, CD8, 
and CD123. Cells are gated on CD4
+
CD8
-
, CD4
+
CD8
low
, CD8
+
CD4
-
 and CD8
+
CD4
low
 
and CD3 and CD123 expression is observed. 
 
IL-3 signaling in iTreg induction 
 We next wanted to determine if CD123 expression was functional and if IL-3 
signaling was playing a role in iTreg induction. The populations described above 
expressed CD123 differently and this dissimilarity in expression may be relevant to the 
differentiation of CD4
+
 iTregs from UCB. Therefore, we hypothesized that IL-3 signaling 
may be influential in CD4
+
 iTreg differentiation. After IL-3 binds to its high affinity 
receptor IL-3Rα (CD123), CD123 then forms a complex with a common beta chain, 
IL-3βc (26). A tyrosine protein kinase, Janus kinase 2 (JAK2), binds to the cytoplasmic 
region of CD123, thus activating JAK2 which sequentially activates IL-3Rβc (36). 
IL-3Rβc now serves as a docking station to activate the signal transducer proteins STATs, 
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such as STAT5 which forms a dimer, enters the nucleus, and regulates gene transcription 
(26). Srivastava et al. has demonstrated that IL-3 signaling though STAT5 increases the 
frequency of functional Foxp3
+
 Treg cells (25). 
 In order to determine if IL-3 was important in iTreg induction in UCB, WCB was 
cultured with either recombinant IL-3 or with an anti-IL-3 neutralizing antibody. If IL-3 
signaling influences iTreg induction, than the addition of IL-3 may increase iTreg 
frequency, while neutralizing IL-3 will block iTreg differentiation. Cell where cultured 
for fourteen days and Treg frequency was determined by FACS. The frequency of Tregs 
is considerably reduced when WCB is treated with anti-IL-3 neutralizing antibody in all 
of the aforementioned populations seen in the CD4/CD8 profile when compared to 
untreated WCB (Figure 10B). The addition of IL-3 maintains the Treg frequency in all 
populations when compared to untreated WCB (Figure 10B); however, there is an 
increase in the frequency of CD4
+
 cells and a decrease in the frequency of CD8
+
 cells 
(Figure 10A). Histogram analysis of CD4
+
CD8
-
 cells in untreated WCB, exogenous IL-3 
treated WCB, and anti-IL-3 antibody treat WCB displays varying expression of CD25; 
however, only a decrease in Foxp3 was observed in anti-IL-3 treated WCB (Figure 11). 
An increase in CD25 expression was observed in WCB treated with exogenous IL-3 
while a decrease in CD25 expression was seen in WCB treated with anti-IL-3 antibody 
when compared to untreated WCB (Figure 11A). These trends were observed in all gated 
populations (data not shown). These data suggest that IL-3 may be vital for the induction 
of iTregs in UCB. 
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Figure 10: Treg frequency of WCB with exogenous IL-3 or anti-IL-3 treatment. 
WCB cultures are stimulated with α-CD3 and IL-2 with or without the addition of either 
exogenous IL-3 or anti-IL-3 antibody. Cells were harvested at day 14 and stained for 
CD4, CD8, CD25 and Foxp3. Cells are gated on CD4
+
CD8
-
, CD4
+
CD8
low
, CD8
+
CD4
-
 
and CD8
+
CD4
low
 (A). Treg frequency is determined by CD25 and Foxp3 expression (B). 
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Figure 11: Foxp3 and CD25 expression with exogenous IL-3 or anti-IL-3 treatment. 
WCB cultures are stimulated with α-CD3 and IL-2 with or without either exogenous IL-3 
or anti-IL-3 antibody. Cells were harvested at day 14 and stained for CD4, CD8, and 
CD25 and Foxp3. Cells are gated on CD4
+
CD8
-
 and CD25 (A) and Foxp3 (B) expression 
is observed. 
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CHAPTER FOUR 
DISCUSSION 
 
Introduction 
 Regulatory T (Treg) cells are a subset of T cells that modulate immune responses 
by maintaining homeostasis and self-tolerance. When an immune response is mounted 
against self-tissue, autoimmunity ensues; thus, Treg function is critical to negatively 
regulate any unwanted immunogenic reaction. The absence or dysfunction of Tregs 
results in a wide array of diseases which includes IPEX, IBD, MS, cancer, allergy and 
infection. Two subsets of Tregs include nTregs and iTregs and is has been proposed that 
the mechanism of development is distinct between the subsets (13). Many factors are 
involved the differentiation and function of immune cells. Understanding what factors are 
important for producing inducible Tregs will enhance our knowledge about the 
mechanisms required for iTreg induction and may lead to the generation Treg based 
therapies. 
 Our laboratory has discovered that human UCB has an increased propensity for 
the differentiation of iTregs compared to adult PBMCs. Upon stimulation of TCR with 
α-CD3 and APC co-stimulation of CD4+ cells in the presents of IL-2 in WCB, CD4+ 
T cells up-regulate the transcription factor Foxp3 and the IL-2 receptor α chain, CD25. It 
has been demonstrated that expression of Foxp3 is stable after fourteen days of culture 
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and this stable expression is associated with suppressive function. When CD4
+
 cells are 
stimulated with α-CD3 and α-CD28 coated polystyrene beads in the presents of IL-2, 
iTreg differentiation is not observed and is used as a non-Treg (CD4
+
CD25
-
Foxp3
-
) 
control. Other groups have reported that histone modifications and cytokine signaling are 
two very important signals vital for the differentiation and function of Tregs 
(14,19,21,23,25,29). This led us to hypothesize that epigenetic histone modifications and 
cytokine signaling are imperative to control the differentiation of iTregs from UCB. This 
ex vivo system allows us to study and better understand the mechanisms that are 
influencing iTreg differentiation. 
 In this study, we focused on two different mechanisms that mediate the processes 
that may be critical for iTreg differentiation in UCB. First, we determined what 
epigenetic modifications on histone tails are involved in the activation of gene expression 
in iTregs. We found that the histone modifications H3K4me3 and H3K9ac decreased 
dramatically in iTreg cells (CD4
+
CD25
+
Foxp3
+
) compared to non-Treg cells 
(CD4
+
CD25
-
Foxp3
-
). Alternatively, no difference was seen in H3S10ph and H4K8ac 
when comparing Treg and non-Treg cells. The cytokine TGF-β is involved in provoking 
the change in H3K4me3 and H3K4ac observed. These data suggest that histone 
rearrangement is required for iTreg differentiation and may be mediated through TGF-β 
signaling. Second, we propose that up-regulation of CD8 on CD4
+
 cells as well as 
up-regulation of CD4 on CD8
+
 cells may represent a more activated phenotype due to the 
increase in CD25 and Foxp3 expression. Third, we established that CD4
+
 iTregs express 
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the IL-3 receptor α chain (CD123) suggesting that IL-3 may be required for iTreg 
induction in UCB. Addition of anti-IL-3 neutralizing antibody to WCB blocks the 
biological function of IL-3 and led to the dramatic decrease in expression of iTreg 
markers CD25 and Foxp3. Conversely, addition of exogenous IL-3 increased expression 
of CD25 while Foxp3 expression was unchanged compared to untreated WCB. These 
data propose that IL-3 may be required for iTreg differentiation. 
 
Histone modifications in iTreg cells 
 Our data reveals that epigenetic modifications of histones are important for the 
differentiation of iTreg cells (CD4
+
CD25
+
Foxp3
+
) from UCB. The histone modification 
H3K4me3 and H3K9ac are decreased in iTreg cells while H3S10ph and H4K8ac are 
unchanged compared to non-Treg cells (CD4
+
CD25
-
Foxp3
-
). To determine if the 
variation detected was dependent on TGF-β signaling, we added exogenous TGF-β to 
CD4
+
 bead simulated cultures and TGF-β inhibitor SB-431542 or anti-TGF-β antibody to 
WCB cultures. The addition of TGF-β to CD4+ bead stimulated cells was able to restore 
expression of CD25 and Foxp3 as well as establish the decrease in H3K4me and H3K9ac 
seen in iTregs from WCB. Inhibition of TGF-β signaling with the small kinase inhibitor 
SB-431542 resulted in a decline of CD25 and Foxp3 expression whereas the anti-TGF- β 
antibody did not have a drastic decrease in CD25 and Foxp3 expression. This may be due 
to the presents of other molecules that are a part of the TGF- β superfamily such as 
activin which may be activating the signaling pathway while SB-431542 inhibited kinase 
activity which completely blocked all signaling. Surprisingly, H3K4me3 and H3K9ac 
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were unchanged in CD4
+
 cells where TGF- β signaling was inhibited compared to 
untreated WCB. However, an increase in frequency of CD4
low
 cells was observed and 
TGF-β inhibition increased H3K4me3 and H3K9ac in CD4- and CD4low cells. These data 
demonstrate that epigenetic modifications of histones are important for iTreg 
differentiation and TGF-β signaling may be modulating this chromatin rearrangement. 
 As previously mentioned, it has been established that TGF-β signaling is an 
essential factor in T cell homeostasis through many cells of the immune system (20). 
TGF-β has been shown to be required for the differentiation of iTregs from naïve CD4+ 
T cells in the periphery (22). Activated TGF-β binds to the TGF-β receptor II and then 
forms a heterodimer with TGF-β receptor I; thus, activating Smad2/3 signaling. Li et al. 
has shown that mice lacking the TGF-β receptor II result in lethal inflammation (19). The 
expression of Foxp3 is mediated by TGF-β singling through the activation of Smad3 and 
its association with the foxp3 promoter (23). Ross et al. has shown that Smad2 recruits 
the histone acetyltransferase p300 to acetylate lysine residue 9 on histone protein H3 to 
promote active gene transcription and many other histone co-activators have been 
implicated in Smad2/3 signaling (21). It has also been established that pro-transcriptional 
modifications H3K9ac at the foxp3 locus has a strongly associated with Treg cells (14). 
Our data illustrate that TGF-β is mandatory for modulating chromatin rearrangement by 
H3K4me3 and H3K9ac histone modifications. Overall, we propose a model that after 
stimulation with TGF-β, naïve CD4+ T cells increase the expression of Foxp3 and CD25 
through TGF-β signaling by first inducing changes in epigenetic modifications of amino 
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acid residues at histone tails which subsequently allows binding of Smads to the open 
promoter of genes important to iTreg differentiation and function. 
 
CD4, CD8 and CD123 expression on iTregs 
 As described above, TGF-β inhibition resulted in an increased frequency of 
CD4
low
 cells. Monocytes express CD4 at low levels and can differentiate into various 
APC subsets including plasmacytoid DCs (pDC) (33). An identifying marker for pDCs is 
the IL-3 receptor α chain, CD123, and it has been shown that pDCs are capable of 
inducing Treg differentiation resulting in suppressive function (34). We wanted to 
determine if the CD4
low
 cells were iTregs or monocytes differentiating into pDC’s. To 
address this question we used FACS cell surface staining to phenotype the CD4
low
 cells. 
These CD4
low
 cells expressed the T cell markers CD8 and CD3 after fourteen days of 
culture. Four populations were seen when looking at the CD4 and CD8 profile. A 
population CD4
+
 cells had CD8 up-regulated on the cell surface and another population 
of CD8
+
 cells had CD4 up-regulated on the cell surface. Sullivan et al. has demonstrated 
that increased expression of CD4 on CD8
+
 cells is an additional marker for activated CD8 
T cells as these CD8
+
CD4
low
 cells expressed higher levels of the activation markers, 
CD95, CD28, and CD25 when compared to CD8
+
CD4
-
 cells (35). Foxp3 and CD25 
expression was increased in the CD4
+
CD8
low
 and CD8
+
CD4
low
 cells when compared to 
CD4
+
CD8
-
 and CD8
+
CD4
-
 respectively. CD8
+
 cells have been shown to up-regulate 
Foxp3 and have been implicated in GVHD (8). Thus, the up-regulation of CD4 on CD8
+
 
cells and CD8 on CD4
+
 cells seen in our UCB system may constitute an additional 
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marker for a more activated iTreg; however, iTreg induction in CD8
+
 cells has not been 
well characterized in this UCB system. Surprisingly, we observed that CD4
+
CD8
-
 and 
CD4
+
CD8
low
 cells expressed high levels of CD123 while CD8
+
CD4
-
 and CD8
+
CD4
low
 
cells did not, suggesting that IL-3 signaling may be important for CD4
+
 iTreg induction. 
 
IL-3 signaling and iTreg differentiation 
 We have demonstrated that IL-3 receptor α chain, CD123, is expressed on CD4+ 
iTregs after fourteen days of culture. Hence, we determined if IL-3 signaling is important 
for the differentiation of CD4
+
 iTregs from UCB. We added anti-IL-3 antibody to 
neutralize the biological function of any IL-3 present in culture or exogenous IL-3 to 
WCB. Our data show that when IL-3 is neutralized, there is a decrease in the expression 
of CD25 and Foxp3 in all four populations observed in the CD4/CD8 profile. We 
observed an increased frequency of CD4
+ 
cells and a decreased frequency of CD8
+ 
cells 
when WCB was treated with exogenous IL-3. The addition of exogenous IL-3 had no 
effect on Foxp3 expression; however, there was an increase in CD25 expression in all of 
the aforementioned populations. These data suggest that IL-3 signaling is required for 
iTreg differentiation. 
 Interleukin 3 signaling is mediated through signal transducers known as STATs. 
IL-3 binds to its cognate receptor, CD123, which allows the association of the IL-3 
common β chain (IL-3βc); thus, leading to activation of a tyrosine protein kinase, JAK2. 
This subsequently activates STATs, specifically STAT5, which forms a dimer to enter 
the nucleus and modulates gene expression. IL-3 has a wide range of functions and it has 
43 
 
 
been previously reported that IL-3 is produced by activated T cells; thus, I hypothesize 
that IL-3 is being produced by activated T cells in our UCB model. Mirabella et al has 
shown that during T cell development, the IL3 locus goes through progressive stages of 
development (37). Immature CD4
+
CD8
+
 double positive thymocytes have the IL3 gene 
epigenetically silent in order to stop any inappropriate cell activation during TCR 
selection (37). Naïve CD4
+
 T cells show low levels of IL-3 expression; however, after 
TCR stimulation, the IL3 locus undergoes chromatin rearrangement allowing for 
intermediate transcription of the IL3 gene (37). Furthermore, the epigenetic imprint is 
maintain in memory T cells which expresses 4 fold more IL-3 mRNA compared to naïve 
cells (37). It is also interesting to note that Th2 cells contain higher levels of IL-3 mRNA 
when compared to Th1 cells (37). Therefore, IL-3 produced by activated T cells in UCB 
may activate the CD14
+
CD36
+
 monocytes that express CD123 at day zero to boost their 
ability to induce iTreg differentiation. Additionally, when CD4
+
 cells up-regulate CD123 
on the cell surface upon TCR activation, IL-3 may be working in an autocrine and/or 
paracrine manner to promote the induction of iTreg cells. 
Seivastava et al. has demonstrated that IL-3 enhances the frequency of Foxp3
+
 
T cells that are able to suppress the function of effector T cells (25). Furthermore, STAT5 
knockout mice have decreased Treg number and defective function of Tregs (29). 
Nakajima et al demonstrates that STAT5
-/-
 splenocytes have reduced CD25 mRNA 
compared to wild type, suggesting that STAT5 is required for CD25 expression which is 
required for iTreg proliferation (30). These data suggest that IL-3 is important for iTreg 
differentiation and we propose IL-3 is important for modulation of CD25 and Foxp3 
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expression. In the future, it would be interesting to further characterize the of role IL-3 
signaling in iTreg differentiation as its importance has been only recently uncovered. 
 
Global Signaling 
We have demonstrated that epigenetic histone modifications, TGF-β, and IL-3 
may all be important for the differentiation of iTregs from UCB. A cell receives a wide 
array of signals which must jointly operate to change the gene expression pattern that is 
required for any cell to differentiate. For the induction of iTregs from UCB, it is not 
merely one signal that instructs a naïve CD4
+
 T cell to express proteins important for 
iTregs such as Foxp3 and CD25; thus, a cascade of events must take place for a cell to 
implement the gene expression pattern important for iTregs differentiation and function. 
Epigenetic histone modifications are not dependent on the sequence of DNA, and 
therefore, a signal must be received in order to induce these changes. DNA 
de-methylation has been associated with histone acetylation and active transcription (14). 
Importantly, DNA methylation status is evolutionarily conserved at specific regions (14). 
Other signals that may promote the rearrangement of chromatin include TGF-β signaling 
by recruiting histone modifying enzymes such as histone acetyltransferases to further 
induce epigenetic changes at promoter regions that support or suppress transcription (21). 
Ross et al. has demonstrated that Smad2/3, the signal transducer for TGF-β signaling, 
associates with the acetyltransferase p300 which is involved in acetylation of histone tails 
(21). Furthermore, Tone et al. also shows the importance of Smad3 for histone 
modifications and then binding to an enhancer region of the foxp3 promoter once the 
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binding site is accessible; however, Smad3 is not mandatory for maintained expression 
(23). TGF-β signaling is involved in the differentiation of many other T cell subsets such 
as Th9 and Th17; consequently, additional factors are a necessity for specific 
up-regulation of genes important for iTreg differentiation. 
Once the chromatin has been remodeled and is in an open confirmation, other 
transcription factors such as STATs can bind for sustained transcription of genes. 
Passerini et al. reveals that cytokines involved in STAT5 signaling are required for Foxp3 
expression in CD4
+
CD25
+
 Tregs (38).Furthermore, Yao et al. has demonstrated that there 
are STAT5 binding sites in highly conserved regions of the foxp3 promoter (39).Thus, I 
hypothesize that TGF-β signaling first induces changes in histone modifications through 
the association of Smads with histone modifying enzymes (Figure 12). This is only a 
preliminary step towards iTreg differentiation. Once the chromatin is in an open 
confirmation, Smads are capable of binding to the open promoter and may serve as an 
additional signal to promote binding of other factors to support transcription of the gene. 
This however is not specific for iTreg differentiation as TGF-β is involved in the 
induction of other cells types. Another molecule that may be specific for iTregs 
differentiation may include IL-3. The signaling pathway of IL-3 may influence CD25 and 
Foxp3 transcription through STAT5 binding to the promoter region to provide stable 
expression (Figure 12). Therefore, all of these factors as well as RNA polymerase may 
form a complex in order to stabilize the transcription of genes required for iTreg 
induction. 
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Figure 12: Mechanistic hypothesis. In WCB cultures stimulated with α-CD3, 
exogenous IL-2, exogenous IL-3 and TGF-β, naïve CD4+ T cells can send a signaling 
cascade through the cell to regulate histone modifications as well as genes expression for 
proteins that are important for Treg function such as Foxp3 and CD25. 
 
Concluding remarks 
My work has exposed important mechanisms that are required for the 
differentiation of iTregs from human UCB. My data suggest that epigenetic modifications 
of amino acid residues at histone tails are imperative for the expression of genes required 
for Treg function. In addition, TGF-β signaling may be important in modulating these 
epigenetic changes through Smad2/3 association with histone modifying enzymes. Also, 
it is important to note that expression of low levels of CD4 on CD8
+
 T cells and low 
levels of CD8 on CD4
+
 T cells correlate to an increase in CD25 and Foxp3 suggesting 
up-regulation of these surface markers denote an additional phenotype of iTregs. 
47 
 
 
Additionally, a novel mechanism that may be crucial for iTreg differentiation may be 
through IL-3 signaling. IL-3 signaling may be required for maintained CD25 and Foxp3 
expression through STAT5 association with the promoter region of these genes. Both 
aforementioned signals must work in an organized fashion for the differentiation of 
iTregs; furthermore, appreciating the mechanisms required for iTreg induction may lead 
to the production of Treg therapeutics to treat immune dysfunction.
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